JIANMIN PHARMACEUTICAL GROUP revenue breakdown overview

JIANMIN PHARMACEUTICAL GROUP revenue for the last year amounted to 3.50 B CNY, the most of which — 3.37 B CNY — came from its highest performing source at the moment, Pharmaceutical Production, the year earlier bringing 4.16 B CNY. The greatest contribution to the revenue figure was made by China — last year it brought JIANMIN PHARMACEUTICAL GROUP 3.50 B CNY, and the year before that — 4.21 B CNY.